Back to search

Article

Widespread genomic heterogeneity at the type II NAD(P)H dehydrogenase locus predisposes <i>Cryptosporidium</i> to clofazimine resistance

2025-10-07

Abstract excerpt

The parasite Cryptosporidium is a leading cause of life-threatening diarrheal disease, and effective treatment is not available. The discovery of potent anti- Cryptosporidium activity of clofazimine, offered the opportunity to repurpose a drug already used to treat leprosy and tuberculosis. However, clofazimine failed in a human trial, which was attributed to poor bioavailability. Here, we observed differential...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c0bc4069-6340-57c0-b219-90036765114f
DOI
10.1101/2025.10.07.680968
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Widespread genomic heterogeneity at the type II NAD(P)H dehydrogenase locus predisposes <i>Cryptosporidium</i> to clofazimine resistanceDOI 10.1101/2025.10.07.680968
Select a neighboring publication to make it the new centre.